Food and Drug Regulations (C.R.C., c. 870)
Full Document:
Regulations are current to 2013-06-10 and last amended on 2013-05-31. Previous Versions
PART J
RESTRICTED DRUGS
Division 1
General
J.01.001. In this Part,
- “competent authority”
“competent authority” means a public authority of a foreign country that is authorized under the laws of the country to approve the importation or exportation of restricted drugs into or from the country; (autorité compétente)
- “institution”
“institution” means any institution engaged in research on drugs and includes a hospital that is licensed by a province, a university, a department or agency of the Government of Canada or of a province or any part thereof; (établissement)
- “international obligation”
“international obligation” means an obligation in respect of a restricted drug set out in a convention, treaty or other multilateral or bilateral instrument that Canada has ratified or to which Canada adheres; (obligation internationale)
- “licence”
“licence”[Repealed, SOR/2004-238, s. 31]
- “licensed dealer”
“licensed dealer” means the holder of a licence issued under section J.01.007.2; (distributeur autorisé)
- “permit”
“permit” means a permit issued under section J.01.005; (permis)
- “practitioner”
“practitioner” means a person who is registered and entitled under the laws of a province to practise the profession of medicine; (praticien)
- “qualified investigator”
“qualified investigator” means, in respect to a restricted drug, a person who
(a) is employed by or is connected with an institution, or
(b) is engaged in research in an institution in respect of that drug,
and whose use and possession of that drug is authorized by the Minister pursuant to section J.01.018; (chercheur compétent)
- “qualified person in charge”
“qualified person in charge” means the individual with the qualifications specified in subsection J.01.003.2(2) who is responsible for supervising the activities carried out by a licensed dealer under their licence at the premises specified in the licence; (personne qualifiée responsable)
- “restricted drug”
“restricted drug” means a drug set out in the schedule to this Part; (drogue d’usage restreint)
- “test kit”
“test kit” means an apparatus
(a) that contains reagent systems or buffering agents or both,
(b) that is used in the course of a chemical or analytical procedure for medical, laboratory, industrial, educational or research purposes, and
(c) the contents of which are not intended for administration to humans. (nécessaire d’essai)
- SOR/97-228, s. 22;
- SOR/2004-238, s. 31.
- Date modified: